Amgen Inc Machine Learning Engineer Interview: Questions, Experience & Prep (2026)

Amgen Inc is a leading global biotechnology company focused on developing medicines for serious conditions. For ML Engineer roles, the interview process is typically thorough and goes beyond standard software engineering interviews, reflecting Amgen's scientific culture. Candidates report the process includes multiple rounds covering coding, machine learning fundamentals, system design, and behavioral questions. As of July 2026, knok's job radar shows Amgen has 89 open roles across the company.

ML engineers at Amgen typically work on applications such as drug discovery models, real-world evidence analysis, and clinical data pipelines. Interviewers generally look for candidates who connect machine learning techniques to real scientific or business outcomes, not just those who can write clean code. Prior experience with healthcare, pharma, or scientific datasets is a genuine advantage, though it is not always a strict requirement.

These questions come up frequently in Amgen ML Engineer interviews, based on what candidates report across multiple hiring cycles:

1. Walk us through an ML project you built end-to-end, from raw data to a working system.
2. How have you handled class imbalance in a dataset, particularly in a medical or scientific context?
3. Explain the bias-variance tradeoff with a practical example from your own work.
4. What is your experience with model interpretability techniques such as SHAP or LIME, and when would you use them?
5. How do you ensure reproducibility across ML experiments and training pipelines?
6. Describe your experience with large-scale data processing tools such as Spark or Dask.
7. How would you design an ML system to predict a clinical outcome from electronic health record data?
8. What is your approach to feature engineering when the domain, such as biology or chemistry, requires subject-matter expertise you may not have?
9. Tell me about a time you had to explain a model's output to a non-technical audience like a clinician or business leader.
10. How do you monitor a model in production, and what signals tell you it is time to retrain?
11. What experience do you have with graph neural networks or other methods suited to structured biological data?
12. Describe a situation where a model you built did not perform as expected. What did you learn and do differently?

Use the STAR format for both behavioral and project-based questions. Here are three worked examples:

---

Q: Walk us through an ML project you built end-to-end.

*Situation:* At my previous company, the clinical operations team needed a way to flag anomalous lab readings in patient data before they reached the reporting team.

*Task:* I was responsible for the full pipeline, from raw data ingestion to a live alert system the clinical team could act on.

*Action:* I began by working with domain experts to understand which anomalies had actual clinical significance. I built a preprocessing pipeline in Python, trained an isolation forest model as a baseline, and compared it against a supervised LSTM on historical flagged records. I used MLflow for experiment tracking and containerized the final model with Docker for deployment on our internal server.

*Result:* The model reduced the manual review queue considerably, and the clinical team reported higher confidence in the alerts. The pipeline ran reliably in production with only minor periodic retraining needed.

---

Q: How have you handled class imbalance in a medical dataset?

*Situation:* I was building a classifier to identify rare adverse drug events in a clinical trial dataset, where positive cases made up a very small fraction of records.

*Task:* My goal was to catch true positives reliably without flooding the review team with false alarms.

*Action:* I combined SMOTE for oversampling during training with class-weighted loss functions in XGBoost. I calibrated probability thresholds using the validation set and reported precision-recall curves rather than accuracy, since accuracy alone was misleading given the skew in the data.

*Result:* The final model caught a substantially higher share of true adverse events compared to the earlier rule-based approach, with a false-positive rate the review team found workable.

---

Q: Tell me about a time you explained a complex model to a non-technical stakeholder.

*Situation:* I had built a survival analysis model to predict which patients were at risk of dropping out of a clinical study early.

*Task:* I needed to present the model's logic and predictions to a group of clinical managers with no machine learning background.

*Action:* I avoided all technical jargon. I used a plain analogy: 'think of it like a weather forecast for each patient, a probability of dropout over the coming month.' I prepared a one-page visual showing the top factors driving predictions, with SHAP values translated into plain language, for example: 'patients who miss visits in the early weeks are flagged as higher risk.' I walked through a few real anonymized patient examples to make it concrete.

*Result:* The clinical team adopted the tool into their monthly review process and told me it was the first ML output they felt comfortable acting on directly.

For technical ML questions, start with a brief definition of the concept, then anchor it in a real project you worked on. Amgen interviewers typically want to see that you understand *why* a technique works, not just that you can name it. Always mention the trade-off you considered or the metric you optimized for.

For system design questions, use a pipeline-first structure: data ingestion, feature engineering, model training, evaluation, deployment, and monitoring. In a life sciences or regulated context, add a note on data traceability and model documentation, since these matter for compliance and audit readiness.

For behavioral questions, use STAR: Situation, Task, Action, Result. Keep the Situation and Task short (one to two sentences each) and spend most of your answer on the Action and Result. If your work involved collaboration with clinicians, scientists, or product teams, call that out explicitly because Amgen values cross-functional work.

For domain-specific questions about biology or pharma, be honest if your background is in a different field. Candidates report that interviewers respond well to people who ask thoughtful clarifying questions about the domain and can articulate how they would get up to speed quickly.

Based on what candidates report from Amgen ML interviews, the team consistently looks for a few things:

Scientific rigour. Amgen's work has direct implications for patient health. Interviewers want to see that you test your assumptions, validate models carefully, and do not overstate what a model can reliably do. Sloppy evaluation or overclaiming results are treated as red flags.

A production mindset. Knowing ML theory is necessary but not sufficient. Candidates who have built and maintained real pipelines, handled data drift, debugged model failures in production, and thought carefully about retraining strategies stand out clearly from those with only academic or competition experience.

Communication across disciplines. ML engineers at Amgen work alongside scientists, clinical researchers, and business teams. The ability to explain your work to people with different backgrounds, and to ask smart domain questions when you do not have all the answers, is genuinely weighted in the evaluation.

Awareness of a regulated environment. Pharma and biotech operate under significant regulatory oversight. Interviewers often probe whether you understand concepts like data lineage, model validation documentation, and the difference between a research prototype and a production-ready system.

Intellectual curiosity about the science. Candidates who show genuine interest in the biological or clinical problems behind the ML work tend to resonate with Amgen's hiring team. You do not need a science degree, but you should be curious enough to ask good questions.

Step 1: Sharpen your ML fundamentals. Review core supervised and unsupervised methods, regularization, model evaluation metrics (especially precision-recall, AUC, and calibration), and common pitfalls like data leakage. Candidates report that Amgen goes deeper on fundamentals than many general technology companies.

Step 2: Prepare two or three strong project stories. For each project, know the business problem, the data, the model choices you made and why, how you evaluated it, and what happened in production. Structure each as a STAR story so you can adapt it to different questions.

Step 3: Read up on life sciences ML applications. You do not need a biology background, but understanding how ML is applied in drug discovery, clinical trials, and patient data analysis helps you engage more confidently with domain-specific scenarios and ask better questions.

Step 4: Practice system design for ML pipelines. Prepare to design a pipeline end-to-end: data ingestion, feature store, training, evaluation, serving, and monitoring. Practice explaining trade-offs out loud, not just writing them on paper.

Step 5: Prepare behavioral stories aligned to Amgen's values. Amgen publicly emphasizes integrity, science, and collaboration. Prepare examples that show scientific rigour, ethical decision-making, and working across teams with different expertise.

Step 6: Prepare smart questions to ask. Asking about team structure, the current ML infrastructure, how models are validated before clinical use, and what the biggest technical challenges are signals genuine interest and seniority. Have at least three questions ready.

While you focus on interview prep, knok checks 150+ job sites nightly, applies to jobs matching your resume, and messages HR for you, so you do not miss Amgen openings as they go live.

Skipping the 'why' on model choices. Saying 'I used XGBoost' without explaining why you chose it over alternatives is a common gap. Interviewers typically push back on this. Be ready to justify every significant technical decision with the trade-offs you considered.

Over-relying on accuracy as a metric. In biomedical datasets, class imbalance is common and accuracy alone is a misleading metric. Mentioning accuracy without qualification signals a lack of domain awareness to Amgen interviewers.

Treating the domain as irrelevant. Candidates who treat Amgen like a generic technology company and show no interest in the science behind the problems typically do not progress far. At minimum, ask thoughtful questions about the domain during the interview itself.

Weak or missing production stories. If your experience is primarily academic or competition-based, you may struggle on questions about monitoring, retraining, and model governance. Try to frame even research work in terms of what would need to happen to move it into a regulated production environment.

Rushing behavioral answers. STAR answers that spend too much time on the Situation and too little on the Action and Result leave interviewers without the evidence they need. Practice keeping your setup brief and expanding on what you actually did and what changed as a result.

Not asking questions. Amgen interviews typically include time for your questions at the end. Candidates who ask nothing, or only ask about compensation at this stage, leave a weak impression. Prepare at least three specific and thoughtful questions.